MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by nikkeron Apr 14, 2015 9:27am

104 Views

Post# 23626669

mir

Medmira grants options to buy 1.02 million shares

2015-04-13 17:18 ET - News Release

Ms. Andrea Young reports

MEDMIRA DIRECTORS GRANTED STOCK OPTIONS

MedMira Inc.'s board of directors and corporate secretary have been granted options to purchase common shares under the company's stock option plan, which was approved by shareholders at the company's annual general and special meeting on Jan. 25, 2013. Marvyn Robar, Hermes Chan, Dr. Colin MacGillivray, Romano Robusto, Dr. Michael Sidler and Robyn Cook were granted a total of 1,021,875 options at an exercise price of 10 cents per share and exercisable for a period of three years ending April 12, 2018.

Bullboard Posts

FE Battery Metals begins 2024 winter drill program